Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Blood (2024) 144 (Supplement 1): 4489.

https://doi.org/10.1182/blood-2024-200914

Published: 2024

Journal Articles

Genetic Evolution from Chronic Myeloproliferative Neoplasms to Acute Myeloid Leukemia: An Analysis of Forty-Six Paired Samples

Hung Chang, Hsiao-Wen Kao, Ming-Chung Kuo, Jin-Hou Wu, Ying-Jung Huang, Ting-Yu Huang, Tung-Huei Lin, Lee-Yung Shih

Blood (2023) 142 (Supplement 1): 3155.

https://doi.org/10.1182/blood-2023-182624

Published: 2023

Journal Articles

Clinical Relevance of Molecular Markers in Taiwan Chinese Patients with Primary Myelofibrosis: Endogenous Erythroid Colony Growth Is the Most Important Predictor of Outcomes

Ming-Chung Kuo, MD, Tzung-Chih Tang, MD, Tung-Liang Lin, MD, Po-Nan Wang, MD, Po Dunn, MD, Jin-Hou Wu, MD, Hung Chang, MD, Tung-Huei Lin, MS, Chia-Hui Chang, BS, I-Jung Wu, MS, Lee-Yung Shih, MD

Blood (2015) 126 (23): 4083.

https://doi.org/10.1182/blood.V126.23.4083.4083

Published: 2015

Journal Articles

Genetic Evolution in Myeloproliferative Neoplasms at Transformation to Secondary Acute Myeloid Leukemia: An Analysis of 22 Paired Samples

Hung Chang, MD, Lee-Yung Shih, MD, Jin-Hou Wu, MD, Po Dunn, MD, Yu-Shu Shih, MS, Chen-Yu Lai, MS

Blood (2014) 124 (21): 1875.

https://doi.org/10.1182/blood.V124.21.1875.1875

Published: 2014

Journal Articles

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

Hsuan-Jen Shih, MD, Lee-Yung Shih, MD, Hung Chang, MD, Ming-Chung Kuo, MD, Tung-Huei Lin, MS, Chen-Yu Lai, MS, Yu-Shu Shih, MS, Yu-Hui Huang, MS, Tung-Liang Lin, MD, Po-Nan Wang, MD, Jin-Hou Wu, MD

Blood (2013) 122 (21): 2786.

https://doi.org/10.1182/blood.V122.21.2786.2786

Published: 2013

Journal Articles

Clinical Utility of PRV-1 mRNA Expression Levels in Polycythemia Vera and Essential Thrombocythemia.

Hung Chang, MD, Yu-Shin Hung, MD, Chia-Hui Chang, Yu-Hui Huang, Tung-Liang Lin, MD, Tung-Huei Lin, Po Dunn, MD, Jin-Hou Wu, MD, Po-Nan Wang, MD, Ming-Chung Kuo, MD, Tzung-Chih Tang, MD, Lee-Yung Shih, MD

Blood (2012) 120 (21): 2846.

https://doi.org/10.1182/blood.V120.21.2846.2846

Published: 2012

Journal Articles

Clinical Implications of Reticulin Fibrosis of Bone Marrow in De Novo Acute Myeloid Leukemia.

Tzung-Chih Tang, MD, Hung Chang, MD, Chien-Feng Sun, MD, Lee-Yung Shih, MD, Po Dunn, MD, Po-Nan Wang, MD, Jin-Hou Wu, MD, Ming-Chung Kuo, MD, Tung-Liang Lin, MD, Yu-Shih Hung, MD, Hsiao-Wen Kao, MD

Blood (2012) 120 (21): 2585.

https://doi.org/10.1182/blood.V120.21.2585.2585

Published: 2012

Journal Articles

Agonist and Antagonist Effects of Diadenosine Tetraphosphate, a Platelet Dense Granule Constituent, on Platelet P2Y 1 , P2Y 12 and P2X 1 Receptors

Hung Chang, Ivan B Yanachkov, Alan D Michelson, YouFu Li, Marc R Barnard, George E Wright, Andrew L Frelinger

Blood (2008) 112 (11): 5368.

https://doi.org/10.1182/blood.V112.11.5368.5368

Published: 2008

Journal Articles

Different Patterns of AML1 Mutations between De Novo Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.

Lee-Yung Shih, Der-Cherng Liang, Chein-Fuang Huang, Ming-Chung Kuo, Tung-Liang Lin, Jen-Fen Fu, Yu-Shu Shih, Jin-Hou Wu, Po-Nan Wang, Po Dunn, Tzung-Chih Tang, Hung Chang

Blood (2007) 110 (11): 2442.

https://doi.org/10.1182/blood.V110.11.2442.2442

Published: 2007

Journal Articles

Comparison of Out-of-Pocket Costs and Quality of Life (QOL) for Patients (pts) with Hodgkin’s Disease (HD), Indolent Non-Hodgkin’s Lymphoma (INHL) and Aggressive Non-Hodgkin’s Lymphoma (ANHL).

Narissa J. Nonzee, BS, Sheila O. Brown, RN BSN MHSA, Chih-Hung Chang, PhD, Andrew M. Evens, DO, Leo I. Gordon, MD, Jane N. Winter, MD, Lee Bowman, PhD, Lucie Kutikova, PhD, Charles L. Bennett, MD, PhD, MPP

Blood (2006) 108 (11): 3332.

https://doi.org/10.1182/blood.V108.11.3332.3332

Published: 2006

Journal Articles

EEC Growth, JAK2 Mutation, PRV-1 Overexpression and X-Chromosome Inactivation Pattern: Predicting Values on Polycythemia Vera Evolution and Risk of Thrombosis in Idiopathic Thrombocytosis.

Lee-Yung Shih, MD, Ching-Tai Lee, BS, Tung-Liang Lin, MD, Chia-Hui Chang, BS, Chein-Fuang Huang, PhD, Po-Nan Wang, MD, Ming-Chung Kuo, MD, Po Dunn, MD, Jin-Hou Wu, MD, Hung Chang, MD, Yii-Jenq Lan, MD, Tzung-Chih Tang, MD

Blood (2006) 108 (11): 2692.

https://doi.org/10.1182/blood.V108.11.2692.2692

Published: 2006

Journal Articles

Mutations of Myeloid Transcription Factors AML1, CEBPα and PU.1 in Patients with De Novo Myelodysplastic Syndrome: An Analysis of Paired Bone Marrow Samples at Diagnosis and at AML Transformation.

Lee-Yung Shih, Der-Cherng Liang, Chein-Fuang Huang, Jin-Hou Wu, Po-Nan Wang, Ming-Chung Kuo, Po Dunn, Tzung-Chih Tang, Tung-Liang Lin, Hung Chang

Blood (2005) 106 (11): 3431.

https://doi.org/10.1182/blood.V106.11.3431.3431

Published: 2005

Journal Articles

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34 + Cells and Their Transmigration Through Reconstituted Basement Membrane

Anna Janowska-Wieczorek, Leah A. Marquez, Jean-Marc Nabholtz, Maria L. Cabuhat, Jencet Montaño, Hung Chang, Jacob Rozmus, James A. Russell, Dylan R. Edwards, A. Robert Turner

Blood (1999) 93 (10): 3379–3390.

https://doi.org/10.1182/blood.V93.10.3379.410k09_3379_3390

Published: 1999

NARROW

Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Genetic Evolution from Chronic Myeloproliferative Neoplasms to Acute Myeloid Leukemia: An Analysis of Forty-Six Paired Samples

Clinical Relevance of Molecular Markers in Taiwan Chinese Patients with Primary Myelofibrosis: Endogenous Erythroid Colony Growth Is the Most Important Predictor of Outcomes

Genetic Evolution in Myeloproliferative Neoplasms at Transformation to Secondary Acute Myeloid Leukemia: An Analysis of 22 Paired Samples

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

Clinical Utility of PRV-1 mRNA Expression Levels in Polycythemia Vera and Essential Thrombocythemia.

Clinical Implications of Reticulin Fibrosis of Bone Marrow in De Novo Acute Myeloid Leukemia.

Agonist and Antagonist Effects of Diadenosine Tetraphosphate, a Platelet Dense Granule Constituent, on Platelet P2Y 1 , P2Y 12 and P2X 1 Receptors

Different Patterns of AML1 Mutations between De Novo Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.

Comparison of Out-of-Pocket Costs and Quality of Life (QOL) for Patients (pts) with Hodgkin’s Disease (HD), Indolent Non-Hodgkin’s Lymphoma (INHL) and Aggressive Non-Hodgkin’s Lymphoma (ANHL).

EEC Growth, JAK2 Mutation, PRV-1 Overexpression and X-Chromosome Inactivation Pattern: Predicting Values on Polycythemia Vera Evolution and Risk of Thrombosis in Idiopathic Thrombocytosis.

Mutations of Myeloid Transcription Factors AML1, CEBPα and PU.1 in Patients with De Novo Myelodysplastic Syndrome: An Analysis of Paired Bone Marrow Samples at Diagnosis and at AML Transformation.

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34 + Cells and Their Transmigration Through Reconstituted Basement Membrane

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only